Omeros Price to Free Cash Flow Ratio 2010-2024 | OMER

Omeros price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as

Omeros Price to Free Cash Flow Ratio 2010-2024 | OMER

Omeros price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$198.6B
Stryker (SYK)$139.1B
Boston Scientific (BSX)$123.3B
Medtronic (MDT)$114.7B
EssilorLuxottica (ESLOY)$106.1B
Haleon (HLN)$47.7B
Lonza Group Ag (LZAGY)$46.2B
ResMed (RMD)$35.7B
Koninklijke Philips (PHG)$29.1B
Terumo (TRUMY)$28.6B
Zimmer Biomet Holdings (ZBH)$21.7B
Baxter (BAX)$19.8B
Insulet (PODD)$16.7B
Smith & Nephew SNATS (SNN)$13.5B
Bio-Rad Laboratories (BIO)$9.6B
Demant (WILYY)$9.2B
BellRing Brands (BRBR)$7.7B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.4B
TG Therapeutics (TGTX)$3.9B
Haemonetics (HAE)$3.8B
Neogen (NEOG)$3.8B
Perrigo (PRGO)$3.8B
GN Store Nord (GNNDY)$3.7B
Prestige Consumer Healthcare (PBH)$3.7B
Envista Holdings (NVST)$3.3B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.7B
Maravai LifeSciences Holdings (MRVI)$2.2B
Green Thumb Industries (GTBIF)$2.2B